Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL
CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL Kang, A., Smyth, B., Neuen, B., Heerspink, H., Di Tanna, G., Neal, B., Zhang, H., Hockham, C., Agarwal, R., Bakris, G., Charytan, D. M., De Zeeuw, D., Greene, T., Levin, A., Pollock, C., Wheeler, D., Zinman, B., Mahaffey, K. W., Perkovic, V., Jardine, M. OXFORD UNIV PRESS. 2020: 1342View details for Web of Science ID 000562392101387